Changes in quality of life following unilateral pallidal stimulation in Parkinson's disease

Journal of Psychosomatic Research

Volumn 46, Issue 3, 1999, Pages 247-255

  Vingerhoets, Guy ^a   Lannoo, Engelien ^a   Van Der Linden, Chris ^a   Caemaert, Jacques ^a   Vandewalle, Veerle ^a   Van Den Abbeele, Dirk ^a   Wolters, Mercedes ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Neurosurgery; Pallidal stimulation; Parkinson's disease; Quality of life; Sickness Impact Profile

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; ELECTROSTIMULATION THERAPY; FETUS (ANATOMY); HEALTH STATUS; HUMAN; PALLIDOTOMY; PARKINSON DISEASE; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; RATING SCALE; SELF REPORT;

EID: 0033057532     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3999(98)00090-7     Document Type: Article

References (30)

1. Aminoff M.J. Treatment of Parkinson's disease. West J Med. 161:1994;303-308.
2. Marsden CD, Parkes JD. Success and problems of long-term levodopa therapy in Parkinson's disease. Lancet 1977;i:345-349.
3. Nutt J.G. On-off phenomenon. relation to levodopa pharmacokinetics and pharmacodynamics Ann Neurol. 22:1987;535-540.
4. Dogali M., Fazzani E., Kolodny E., Eidelberg D., Sterio D., Devinsky O., Beric A. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology. 45:1995;753-761.
5. Iacono R.P., Losner R.R., Mandybur G., Morenski J.D., Yamada S., Shima F. Stereotactic pallidotomy results for Parkinson's exceed those of fetal graft. Am Surg. 60:1994;777-782.
6. Iacono R.P., Losner R.R., Oh A., Yamada S. New pathophysiology of Parkinson's disease revealed by posteroventral pallidotomy. Neurol Res. 17:1994;178-180.
7. Klockgether T., Loschmann P.A., Wullner U. New medical and surgical treatments for Parkinson's disease. Curr Opin Neurol. 7:1994;346-352.
8. Lozano A.M., Lang A.E., Galvez-Jimenez N., Miyasaka J., Duff J., Hutchinson W.D., Dostrovsky J.O. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet. 346:1995;1383-1387.
9. Laitinen L.V. Ventroposterolateral pallidotomy. Stereotact Funct Neurosurg. 62:1994;41-52.
10. Eidelberg D., Moeller J.R., Ishikawa T., Dhawan V., Spetsieris P., Silbersweig D., Stern E., Woods R.P., Fazzini E., Dogali M., Beric A. Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease. Ann Neurol. 39:1996;450-459.
11. Grafton S.T., Waters C., Sutton J., Lew M.F., Couldwell W. Pallidotomy increases activity of motor association cortex in Parkinson's disease. a positron emission tomographic study Ann Neurol. 37:1995;776-783.
12. Laitinen L.V., Bergenheim A.T., Hariz M.I. Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms. Stereotact Funct Neurosurg. 58:1992;14-21.
13. Iacono R.P., Lonser R.R., Maeda G., Kuniyoshi S., Warner D., Mandybur G., Yamada S. Chronic anterior pallidal stimulation for Parkinson's disease. Acta Neurochir Wien. 137:1995;106-112.
14. Iacono R.P., Lonser R.R., Mandybur G., Yamada S. Stimulation of the globus pallidus in Parkinson's disease. Br J Neurosurg. 9:1995;505-510.
15. Siegfried J., Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum. a new therapeutic approach for alleviating all parkinsonian symptoms Neurosurgery. 35:1994;1126-1129.
16. van der Linden C., Caemaert J., Vandewalle V., Van den Abbeele D., Lagae B. Chronic unilateral stimulation of the internal globus pallidus (GPi) in advanced Parkinson's disease (PD). a 3 month follow-up in 9 patients Neurology. 48:1997;A430.
17. Fahn S, Elton R, and members of UPDRS Development Committee. In: Fahn S, Marsden CD, Caine DB, Goldstein M, eds. Recent developments in Parkinson's disease, vol 2. Florham Park, New Jersey: Macmillan Health Care Information 1987.
18. Parkinson Study Group Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med. 328:1989;176-183.
19. Blaxter M. Self-definition of health status and consulting rates in primary care. J Soc Affairs. 1:1985;131-171.
20. World Health Organization Constitution of the World Health Organization. 1947;WHO, Geneva.
21. Bergner M., Bobbitt R.A., Carter W.B., Gilson B.S. The Sickness Impact Profile. development and final revision of a health status measure Med Care. 19:1981;787-805.
22. Bergner M., Bobbitt R.A., Kressel S., Pollard W.E., Gilson B.S., Morris J.R. The sickness impact profile. conceptual formulation and methodology for the development of a health status measure Int J Health Serv. 6:1976;393-415.
23. Carter W.B., Bobbitt R.A., Bergner M., Gilson B.S. Validation of an interval scaling. the Sickness Impact Profile Health Serv Res. 11:1976;516-528.
24. Gilson B.S., Gilson J.S., Bergner M., Bobbitt S., Kressel S., Pollard W.E. The Sickness Impact Profile. development of an outcome measure for health care Am J Publ Health. 65:1975;1304-1310.
25. Jacobs H.M., Luttik A., Touw-Otten F.W.M.M., de Melker R.A. The "Sickness Impact Profile" results of a validation study of the Dutch version [summary in English] Ned Tijdschr Geneeskd. 134:1990;1950-1954.
26. Beck A.T., Steer R.A. Beck Depression Inventory manual. 1993;Psychological Corp, San Antonio, Texas.
27. Clark D.A., Steer R.A. Use of nonsomatic symptoms to differentiate clinically depressed and nondepressed hospitalized patients with chronic medical illnesses. Psychol Rep. 75:1994;1089-1090.
28. Plumb M.M., Holland J. Comparative studies of psychological function in patients with advanced cancer. I. Self-reported depressive symptoms. Psychosom Med. 39:1977;264-279.
29. Vingerhoets G. Perioperative anxiety and depression in open-heart surgery. Psychosomatics. 39:1998;30-37.
30. Shindler J.S., Brown R., Welburn P., Parkes J.D. Measuring the quality of life of patients with Parkinson's disease. Walker S.R., Rosser R.M. Quality of life assessment. key issues in the 1990s:1993;Kluwer, Dordrecht.